Abaxis, Inc. to Present at Stephens Fall Investment Conference
UNION CITY, Calif., Nov. 9, 2010 - Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Donald Wood, chief operations officer, will present at the Stephens Fall Investment Conference on Wednesday, November 17, 2010 at 11:30 a.m. ET. The conference will be held at the New York Palace Hotel in New York City.
About Abaxis
Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.
SOURCE Abaxis, Inc.
Contact:
Clint Severson
Chief Executive Officer
ABAXIS, Inc.
510-675-6500
Lytham Partners, LLC
Joe Dorame, Joe Diaz &
Robert Blum
602-889-9700
Web Site: www.abaxis.com
